Top Menu

An Open Letter From DTC Perspectives Founder Bob Ehrlich on Marketing at the Point of Care

Dear Industry Member, Patients are becoming more involved in treatment decisions. DTC advertising, higher co-pays, higher deductibles, less time with doctors, and the availability of health information have made patients into proactive consumers. For this reason, we are debuting the “Point of Care Marketing Conference (http://www.cvent.com/events/the-new-point-of-care-marketing-conference/event-summary-68ed247aa8a6433b8a9aba71544d7f03.aspx)” this fall.  We invite you to join us on […]

Continue Reading

Very Different Futures

Very Different Futures “DTC status quo odds…30%, decline… 20%, growth…50%.” -Bob Ehrlich I love science documentaries about the universe and science fiction about what the earth will be like hundreds of years from now. I am a big Fringe fan. Both genres make you think about potential alternate futures. Forecasts are designed usually to create […]

Continue Reading

Provenge and the DTC Dilemma

Provenge and the DTC Dilemma “Small market drugs can use DTC given high revenue per patient.” -Bob Ehrlich Provenge from Dendreon treats advanced prostate cancer and can prolong life. It is an expensive drug, costing around $90,000 for the three infusions. The clinical studies showed a significant survival increase versus men not treated. The results […]

Continue Reading

The Rise of Self-Screening

The Rise of Self-Screening “We can use technology to greatly increase disease awareness..” -Bob Ehrlich An announcement that Walmart is testing health kiosks is getting a lot of attention. These kiosks, from Solo Health, will give consumers a chance to self-test eyesight, weigh themselves, take blood pressure, and enter health practices into a computer. We […]

Continue Reading

JAMA Publishes Physician Influence Study

JAMA Publishes Physician Influence Study “Critics usually blame DTC for these patient requests.” -Bob Ehrlich A study conducted by The Morgan Institute for Health Policy at Massachusetts General Hospital has some potentially controversial results for brand marketers. The study was done via the web with 1891 responding doctors. The study was designed to measure how […]

Continue Reading